Real-World Evidence (RWE) jobs for Health Economists.
Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Titusville, NJ / Horsham, PA, US. Johnson & Johnson is currently seeking an Associate Director, VAP Innovation & Analytics to join our Value, Access, and Pricing team located in Titusville, NJ or Horsham, PA. As the Associate Director of Value, Access, & Pricing Deal Optimization, you will shape key priorities for Johnson & Johnson Innovative Medicine – including advancing our … Read more
Boston, MA, US. Reporting to the Global Head of the Real World Evidence, the Senior Director of Real World Evidence is responsible for establishing rigorous assessment of real world data to assess the natural history of disease and real world outcomes for the Vertex early development and clinical portfolio. The Senior Director of RWE will shape and influence all aspects … Read more
New Haven, CT, US. The Director, US Health Economics and Outcomes Research (US HEOR) leads the dissemination of real-world evidence to external stakeholders at targeted US payers & health systems in support of the reimbursement landscape of Alexion’s products. Through the partnership with cross-functional teams, this individual is responsible for implementing US HEOR strategies that demonstrate the value and corresponding … Read more
Mississauga, Canada. We are looking for a quantitative epidemiologists, bioinformaticians, health informaticians, biomedical data scientists, clinicians/pharmacologists, bio-statisticians or related fields with a strong desire to learn and expand their abilities into the analysis of Real World Evidence (RWE). The role holder will be a subject matter expert on the use of Real World Data and its capabilities in the use of RWD. The … Read more
Seoul, South Korea. Works directly with clients to provide value added input, to develop business opportunities that will lead to additional starbursts and to deliver projects built around strategic issues. Has responsibility for ensuring delivery of high levels of client satisfaction. Typically works within a specific CoE area but may have responsibility across multiple expertise areas and/or clients. Meets or … Read more
Seoul, South Korea. Are you passionate about driving strategic initiatives and programs in the field of Real World Evidence (RWE)? Do you have experience in managing teams and engaging with stakeholders? If so, we have an exciting opportunity for you to join our Clinical, Medical, Regulatory Affairs (CMR) department as a Real World Evidence Manager. Read on to learn more … Read more
New Haven, CT, US. The Director, US Health Economics and Outcomes Research (US HEOR) leads the dissemination of real-world evidence to external stakeholders at targeted US payers & health systems in support of the reimbursement landscape of Alexion’s products. Through the partnership with cross-functional teams, this individual is responsible for implementing US HEOR strategies that demonstrate the value and corresponding … Read more
Home-based, US. Let’s do this. Let’s change the world! In this vital role, you will be responsible for implementing HEOR strategy, aligned with the Access Strategy Lead (ASL), for one or several assets across the life cycle management. You will be responsible for execution of deliverables whilst engaging with internal and external collaborators. Key responsibilities include: Generating global-impact payer-relevant evidence, … Read more
Tips and tricks to improve your CV and boost your health economics career. Are you tired of submitting countless job applications and never hearing back? Have you ever wondered why some job-seeking health economists seem to have all the luck? The answer is simple – they know how to create a winning CV that gets them hired. If you want … Read more
Real-World Evidence in Health Economics
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Altijd actief
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.